Market Place
Sourcing Support
All News #Library
Others
Synchron raises $75 mn Series C Led by ARCH Venture Partners
16 Dec 2022 //
INDIANPHARMAPOST
Two Indian CROs under lens as United States raises data integrity issues
27 Sep 2021 //
ECONOMIC TIMES
Synchron bags $10M NIH grant to kick off U.S. trial
26 Aug 2021 //
FIERCE BIOTECH
Synchron’s Stentrode receives US FDA breakthrough device designation
30 Aug 2020 //
PHARMABIZZ
Australia to study first interventional neuromodulation platform
26 Jun 2020 //
BIOSPECTRUMASIA
AUD$1.5M NHMRC Awards Grant to Expand Feasibility Trials for Stentrode
24 Jun 2020 //
PRNASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.